MedicaidPrior AuthMedium impact
Policy Updates and Changes to Clinical Review Criteria pdf
Connecticut Medicaid (HUSKY Health)·CT · Oncology, Hematology, Pediatrics·Provider Bulletin
Effective date
Nov 1, 2020
We identified it
Jun 20, 2026
Summary
Connecticut Medicaid (CMAP) is implementing prior authorization requirements for TECARTUS™ (a new cancer treatment) and updating clinical review criteria for genetic testing, organ transplant, and other specialized services. New and updated prior authorization forms are now available.
Action Required
By November 1, 2020: Billing teams must obtain prior authorization for TECARTUS™ (brexucabtagene autoleucel) before administration. Download updated PA forms for Synagis, genetic testing, and Zulresso from the HUSKY Health website. For prior authorization questions, contact CHNCT at 1-800-440-5071.